BRAZIL POTASH PRÉ-VENDE 91% DA PRODUÇÃO FUTURA, CATALISANDO

Acordo final de offtake de mineral crítico com Kimia Solutions é fundamental para obter financiamento de projeto para construção Avança objetivo de autonomia de fertilizantes do Brasil via contrato com distribuidor doméstico líder Terceiro acordo vinculante de Take-or-Pay após offtakes da Keytrade e AMAGGI Compromissos combinados totalizam aproximadamente 91% da produção planejada, pré-vendida para contratos … Read more

ZenaTech’s ZenaDrone to Exhibit at Defense & Security 2025

VANCOUVER, British Columbia, Oct. 28, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a business technology solution provider specializing in AI-driven drones, Drone as a Service (DaaS), Enterprise SaaS, and Quantum Computing solutions, announces that teams from its ZenaDrone and Taiwan-based Spider Vision Sensors manufacturing subsidiaries will be exhibiting and … Read more

374Water Secures Order from City of Olathe for AirSCWO 6

System to be Used to Assess Scale-Up of Advanced AirSCWO Technology for Sustainable Sludge Management and Additional Waste Streams MORRISVILLE, N.C., Oct. 28, 2025 (GLOBE NEWSWIRE) — 374Water Inc. (NASDAQ: SCWO) (“374Water” or the “Company”), a global leader in organic waste destruction technology for industrial, municipal, and federal markets, and the City of Olathe, KS … Read more

Mathematicians Make Surprising Breakthrough in 3D Geometry with ‘Noperthedron’

October 28, 2025 2 min read This New Shape Breaks an ‘Unbreakable’ 3D Geometry Rule The noperthedron has a surprising property—which disproves a long-standing conjecture By Emma R. Hasson edited by Sarah Lewin Frasier Can you drill a hole in a cube that an identical cube could fall through? Prince Rupert of the Rhine first … Read more

Enlivex Therapeutics to Present Phase IIa 3-month Data of

Ness-Ziona, Israel, Oct. 28, 2025 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced that it will present a late-breaking poster abstract at the American College of Rheumatology (ACR) Convergence 2025, taking place October 24–29 at McCormick Place Convention Center in Chicago, Illinois. The presentation will … Read more

Clearmind Medicine CEO Dr. Adi Zuloff-Shani to Speak at

Vancouver, Canada, Oct. 28, 2025 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel neuroplastogen-derived therapeutics to solve major under-treated health problems, is proud to announce that its CEO, Dr. Adi Zuloff-Shani, will participate as a featured speaker at … Read more